Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes
Fig 3
Number of macrophages in colorectal cancers, using CD68 and CD163 markers.
Boxplots depict the number of (A, C) CD68+ and (B, D) CD163+ cells (A, B) in CRCs with and without VEGFA amplification/polysomy and (C, D) in CRCs of intermediate and high grade.